INIT Versus IASTM In Patients With Chronic PF
ConditionPlanter Fasciitis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-60
SponsorCairo University
About this trial
1. To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on general pain intensity in patient with chronic plantar fasciitis. 2. To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on pain intensity at initial morning step in patient with chronic plantar fasciitis. 3. To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on pain pressure threshold in patient with chronic plantar fasciitis. 4. To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on active dorsiflexion ROM in patient with chronic plantar fasciitis. 5. To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on functional disability in patient chronic plantar fasciitis.
5\) Investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on functional disability in patient chronic plantar fasciitis.
Eligibility criteria
Qualifiers
Patient with history of plantar fasciitis more than three months ago.
Plantar heel pain with first few steps upon walking in the morning and after prolonged rest.
Patient's Age between 40-60 years old.
Patient's Body mass index (BMI 18 to 29.9kg/m2).
Disqualifiers
Patients with any prior surgery to distal tibia, fibula, ankle joint or rear foot region.
Presence of any red flags i.e., tumor, fracture, and heterotrophic ossification and had acute inflammatory condition at ankle-foot region were excluded from the study.
Deformity of foot and ankle complex and subjects with referred pain due to sciatica and other neurological disorder.
Trial design
Treatments tested in this trial
- integrated neuromuscular inhibition technique
- instrument assissted soft tissue mobilization
- convential treatment
Treatment groups
54 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov